scorecardDrugmaker Madrigal just came out with some promising data for its treatment of NASH, a 'silent disease' millions are living with - and the stock is exploding
  1. Home
  2. Science
  3. Health
  4. Drugmaker Madrigal just came out with some promising data for its treatment of NASH, a 'silent disease' millions are living with - and the stock is exploding

Drugmaker Madrigal just came out with some promising data for its treatment of NASH, a 'silent disease' millions are living with - and the stock is exploding

Drugmaker Madrigal just came out with some promising data for its treatment of NASH, a 'silent disease' millions are living with - and the stock is exploding
LifeScience1 min read
A piece of healthy liver that was removed from a person rests in a bag before being transplanted.    Associated Press

  • Madrigal Pharmaceuticals just came out with positive new data for its treatment of a "silent" disease millions are living with.
  • The condition, NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people. There are no approved treatments for NASH, though there are some in late-stage development with data expected in 2019.
  • Madrigal showed in a phase 2 study with 73 patients that its treatment was better than placebo at reducing fat in the liver, and the treatment managed to resolve NASH in 27% of the patients who received treatment, compared to just 6% of those in the placebo group.
  • Madrigal's stock was up 60% before markets opened on Thursday on the results.

Markets Insider

NOW WATCH: 80% of startup money goes to 3 states - here's what one visionary is doing to help spread the wealth

READ MORE ARTICLES ON




Advertisement